Risk factors for intensive care unit admission and mortality in hospitalized COVID-19 patients

Documenti analoghi

• Frequency and Cause of Readmissions in Sepsis Patients Presenting to a Tertiary Care Hospital in a Low Middle Income Country
  di: Arshad, Ainan, et al.
  Pubblicazione: (2020)
• Tocilizumab therapy reduced intensive care unit admissions and/or mortality in COVID-19 patients
  di: Klopfenstein, T., et al.
  Pubblicazione: (2020)
• Association of Intravenous Bamlanivimab Use with Reduced Hospitalization, Intensive Care Unit Admission, and Mortality in Patients with Mild to Moderate COVID-19
  di: Ganesh, Ravindra, et al.
  Pubblicazione: (2021)
• Are Biochemical Markers Important in Predicting Intensive Care Unit Admission and Mortality in COVID-19 Patients?
  di: İhsan Solmaz, et al.
  Pubblicazione: (2021-07-01)
• Higher Mortality and Intensive Care Unit Admissions in COVID-19 Patients with Liver Enzyme Elevations
  di: Taramasso, Lucia, et al.
  Pubblicazione: (2020)